UniProt ID | SHOT1_HUMAN | |
---|---|---|
UniProt AC | A0MZ66 | |
Protein Name | Shootin-1 {ECO:0000312|HGNC:HGNC:29319} | |
Gene Name | SHTN1 {ECO:0000312|HGNC:HGNC:29319} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 631 | |
Subcellular Localization | Perikaryon . Cell projection, axon . Cell projection, growth cone . Cytoplasm, cytoskeleton . Cell projection, filopodium . Cell projection, lamellipodium . Localizes in multiple growth cones at neurite tips before the neuronal symmetry-breaking step | |
Protein Description | Involved in the generation of internal asymmetric signals required for neuronal polarization and neurite outgrowth. Mediates netrin-1-induced F-actin-substrate coupling or 'clutch engagement' within the axon growth cone through activation of CDC42, RAC1 and PAK1-dependent signaling pathway, thereby converting the F-actin retrograde flow into traction forces, concomitantly with filopodium extension and axon outgrowth. Plays a role in cytoskeletal organization by regulating the subcellular localization of phosphoinositide 3-kinase (PI3K) activity at the axonal growth cone. Plays also a role in regenerative neurite outgrowth. In the developing cortex, cooperates with KIF20B to promote both the transition from the multipolar to the bipolar stage and the radial migration of cortical neurons from the ventricular zone toward the superficial layer of the neocortex. Involved in the accumulation of phosphatidylinositol 3,4,5-trisphosphate (PIP3) in the growth cone of primary hippocampal neurons.. | |
Protein Sequence | MNSSDEEKQLQLITSLKEQAIGEYEDLRAENQKTKEKCDKIRQERDEAVKKLEEFQKISHMVIEEVNFMQNHLEIEKTCRESAEALATKLNKENKTLKRISMLYMAKLGPDVITEEINIDDEDSTTDTDGAAETCVSVQCQKQIKELRDQIVSVQEEKKILAIELENLKSKLVEVIEEVNKVKQEKTVLNSEVLEQRKVLEKCNRVSMLAVEEYEEMQVNLELEKDLRKKAESFAQEMFIEQNKLKRQSHLLLQSSIPDQQLLKALDENAKLTQQLEEERIQHQQKVKELEEQLENETLHKEIHNLKQQLELLEEDKKELELKYQNSEEKARNLKHSVDELQKRVNQSENSVPPPPPPPPPLPPPPPNPIRSLMSMIRKRSHPSGSGAKKEKATQPETTEEVTDLKRQAVEEMMDRIKKGVHLRPVNQTARPKTKPESSKGCESAVDELKGILGTLNKSTSSRSLKSLDPENSETELERILRRRKVTAEADSSSPTGILATSESKSMPVLGSVSSVTKTALNKKTLEAEFNSPSPPTPEPGEGPRKLEGCTSSKVTFQPPSSIGCRKKYIDGEKQAEPVVVLDPVSTHEPQTKDQVAEKDPTQHKEDEGEIQPENKEDSIENVRETDSSNC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MNSSDEEK -------CCCHHHHH | 11.22 | - | |
3 | Phosphorylation | -----MNSSDEEKQL -----CCCHHHHHHH | 37.56 | 29116813 | |
4 | Phosphorylation | ----MNSSDEEKQLQ ----CCCHHHHHHHH | 44.00 | 29116813 | |
14 | Phosphorylation | EKQLQLITSLKEQAI HHHHHHHHHHHHHHH | 36.28 | 25159151 | |
15 | Phosphorylation | KQLQLITSLKEQAIG HHHHHHHHHHHHHHH | 30.37 | 25159151 | |
17 | Neddylation | LQLITSLKEQAIGEY HHHHHHHHHHHHHHH | 47.77 | 32015554 | |
17 | Ubiquitination | LQLITSLKEQAIGEY HHHHHHHHHHHHHHH | 47.77 | 21906983 | |
17 (in isoform 1) | Ubiquitination | - | 47.77 | 21906983 | |
17 (in isoform 2) | Ubiquitination | - | 47.77 | 21906983 | |
17 (in isoform 3) | Ubiquitination | - | 47.77 | 21906983 | |
17 (in isoform 4) | Ubiquitination | - | 47.77 | 21906983 | |
24 | Phosphorylation | KEQAIGEYEDLRAEN HHHHHHHHHHHHHHH | 14.99 | 21945579 | |
24 (in isoform 3) | Phosphorylation | - | 14.99 | 27642862 | |
29 | Ubiquitination | GEYEDLRAENQKTKE HHHHHHHHHHHHHHH | 27.65 | 32015554 | |
35 | Acetylation | RAENQKTKEKCDKIR HHHHHHHHHHHHHHH | 63.31 | 19829747 | |
37 | Acetylation | ENQKTKEKCDKIRQE HHHHHHHHHHHHHHH | 49.65 | 19829755 | |
41 | Phosphorylation | TKEKCDKIRQERDEA HHHHHHHHHHHHHHH | 3.34 | 32142685 | |
54 (in isoform 7) | Ubiquitination | - | 64.91 | 21906983 | |
73 (in isoform 7) | Ubiquitination | - | 10.46 | 21906983 | |
82 | Phosphorylation | IEKTCRESAEALATK HHHHHHHHHHHHHHH | 16.44 | 28985074 | |
89 | Ubiquitination | SAEALATKLNKENKT HHHHHHHHHHHHCHH | 44.44 | 32015554 | |
99 | Ubiquitination | KENKTLKRISMLYMA HHCHHHHHHHHHHHH | 29.35 | 30230243 | |
101 | Phosphorylation | NKTLKRISMLYMAKL CHHHHHHHHHHHHHH | 13.53 | 22617229 | |
104 | Phosphorylation | LKRISMLYMAKLGPD HHHHHHHHHHHHCCC | 6.08 | 30108239 | |
109 | Ubiquitination | MLYMAKLGPDVITEE HHHHHHHCCCEEEEE | 18.69 | 32015554 | |
111 | Ubiquitination | YMAKLGPDVITEEIN HHHHHCCCEEEEEEC | 42.52 | 30230243 | |
112 (in isoform 7) | Ubiquitination | - | 7.03 | 21906983 | |
121 | Ubiquitination | TEEINIDDEDSTTDT EEEECCCCCCCCCCC | 58.78 | 30230243 | |
158 | 2-Hydroxyisobutyrylation | IVSVQEEKKILAIEL HCCHHHHHHHHHEEH | 44.34 | - | |
159 | Ubiquitination | VSVQEEKKILAIELE CCHHHHHHHHHEEHH | 46.35 | 30230243 | |
169 | Ubiquitination | AIELENLKSKLVEVI HEEHHHHHHHHHHHH | 58.06 | 30230243 | |
170 | Ubiquitination | IELENLKSKLVEVIE EEHHHHHHHHHHHHH | 34.09 | 30230243 | |
171 | Ubiquitination | ELENLKSKLVEVIEE EHHHHHHHHHHHHHH | 55.77 | 30230243 | |
181 | Ubiquitination | EVIEEVNKVKQEKTV HHHHHHHHHHHHHHH | 56.86 | 30230243 | |
187 | Phosphorylation | NKVKQEKTVLNSEVL HHHHHHHHHCCHHHH | 29.49 | 29978859 | |
189 | Phosphorylation | VKQEKTVLNSEVLEQ HHHHHHHCCHHHHHH | 7.65 | 32142685 | |
191 | Phosphorylation | QEKTVLNSEVLEQRK HHHHHCCHHHHHHHH | 25.56 | 29978859 | |
204 (in isoform 7) | Ubiquitination | - | 59.46 | 21906983 | |
211 | Ubiquitination | NRVSMLAVEEYEEMQ CCCEEEEHHHHHHHH | 5.17 | 29967540 | |
214 | Phosphorylation | SMLAVEEYEEMQVNL EEEEHHHHHHHHHHH | 12.04 | - | |
214 (in isoform 3) | Phosphorylation | - | 12.04 | 27642862 | |
228 | Ubiquitination | LELEKDLRKKAESFA HHHHHHHHHHHHHHH | 48.87 | 30230243 | |
229 | Ubiquitination | ELEKDLRKKAESFAQ HHHHHHHHHHHHHHH | 64.73 | 30230243 | |
230 | Ubiquitination | LEKDLRKKAESFAQE HHHHHHHHHHHHHHH | 51.45 | 30230243 | |
233 | Phosphorylation | DLRKKAESFAQEMFI HHHHHHHHHHHHHHH | 30.64 | 27251275 | |
249 | Phosphorylation | QNKLKRQSHLLLQSS HCHHHHHHHHHHHCC | 21.82 | 25159151 | |
249 (in isoform 2) | Phosphorylation | - | 21.82 | - | |
255 | Phosphorylation | QSHLLLQSSIPDQQL HHHHHHHCCCCHHHH | 30.15 | 23403867 | |
256 | Phosphorylation | SHLLLQSSIPDQQLL HHHHHHCCCCHHHHH | 25.77 | 23403867 | |
263 | Ubiquitination | SIPDQQLLKALDENA CCCHHHHHHHHHHHH | 2.37 | 30230243 | |
271 | Ubiquitination | KALDENAKLTQQLEE HHHHHHHHHHHHHHH | 64.74 | 29967540 | |
275 | Ubiquitination | ENAKLTQQLEEERIQ HHHHHHHHHHHHHHH | 45.68 | 29967540 | |
288 | Ubiquitination | IQHQQKVKELEEQLE HHHHHHHHHHHHHHH | 64.71 | 30230243 | |
323 | Ubiquitination | DKKELELKYQNSEEK HHHHHHHHHCCHHHH | 35.10 | 30230243 | |
324 | Phosphorylation | KKELELKYQNSEEKA HHHHHHHHCCHHHHH | 26.08 | 23403867 | |
332 | Ubiquitination | QNSEEKARNLKHSVD CCHHHHHHHHHHHHH | 61.14 | 33845483 | |
335 | Ubiquitination | EEKARNLKHSVDELQ HHHHHHHHHHHHHHH | 37.07 | 29967540 | |
337 | Phosphorylation | KARNLKHSVDELQKR HHHHHHHHHHHHHHH | 29.67 | 18452278 | |
337 (in isoform 2) | Phosphorylation | - | 29.67 | - | |
346 | Ubiquitination | DELQKRVNQSENSVP HHHHHHHHHCCCCCC | 43.63 | 32015554 | |
346 (in isoform 5) | Ubiquitination | - | 43.63 | 21906983 | |
348 | Phosphorylation | LQKRVNQSENSVPPP HHHHHHHCCCCCCCC | 33.28 | 27174698 | |
351 | Phosphorylation | RVNQSENSVPPPPPP HHHHCCCCCCCCCCC | 31.76 | 27174698 | |
372 | Phosphorylation | PPPNPIRSLMSMIRK CCCCHHHHHHHHHHH | 29.19 | 27174698 | |
375 | Phosphorylation | NPIRSLMSMIRKRSH CHHHHHHHHHHHCCC | 19.15 | 27422710 | |
376 (in isoform 6) | Ubiquitination | - | 1.82 | 21906983 | |
381 | Phosphorylation | MSMIRKRSHPSGSGA HHHHHHCCCCCCCCC | 42.67 | 27282143 | |
384 | Phosphorylation | IRKRSHPSGSGAKKE HHHCCCCCCCCCCCC | 39.92 | 26091039 | |
386 | Phosphorylation | KRSHPSGSGAKKEKA HCCCCCCCCCCCCCC | 39.66 | 23312004 | |
390 | Ubiquitination | PSGSGAKKEKATQPE CCCCCCCCCCCCCCC | 65.01 | 29967540 | |
392 | Ubiquitination | GSGAKKEKATQPETT CCCCCCCCCCCCCCH | 66.66 | 33845483 | |
394 | Phosphorylation | GAKKEKATQPETTEE CCCCCCCCCCCCHHH | 56.58 | 21815630 | |
398 | Phosphorylation | EKATQPETTEEVTDL CCCCCCCCHHHHHHH | 46.31 | 20068231 | |
398 | Ubiquitination | EKATQPETTEEVTDL CCCCCCCCHHHHHHH | 46.31 | 27667366 | |
398 (in isoform 2) | Phosphorylation | - | 46.31 | - | |
399 | Phosphorylation | KATQPETTEEVTDLK CCCCCCCHHHHHHHH | 28.61 | 20068231 | |
399 (in isoform 2) | Phosphorylation | - | 28.61 | - | |
403 | Phosphorylation | PETTEEVTDLKRQAV CCCHHHHHHHHHHHH | 38.60 | 27135362 | |
404 | Phosphorylation | ETTEEVTDLKRQAVE CCHHHHHHHHHHHHH | 56.20 | 33259812 | |
406 | 2-Hydroxyisobutyrylation | TEEVTDLKRQAVEEM HHHHHHHHHHHHHHH | 45.32 | - | |
406 | Acetylation | TEEVTDLKRQAVEEM HHHHHHHHHHHHHHH | 45.32 | 24430961 | |
406 | Methylation | TEEVTDLKRQAVEEM HHHHHHHHHHHHHHH | 45.32 | 24430961 | |
406 | Ubiquitination | TEEVTDLKRQAVEEM HHHHHHHHHHHHHHH | 45.32 | 21906983 | |
406 (in isoform 1) | Ubiquitination | - | 45.32 | 21906983 | |
406 (in isoform 2) | Ubiquitination | - | 45.32 | 21906983 | |
406 (in isoform 3) | Ubiquitination | - | 45.32 | 21906983 | |
406 (in isoform 4) | Ubiquitination | - | 45.32 | 21906983 | |
406 (in isoform 5) | Ubiquitination | - | 45.32 | 21906983 | |
416 | Methylation | AVEEMMDRIKKGVHL HHHHHHHHHHCCCCC | 25.40 | 115916949 | |
425 | Ubiquitination | KKGVHLRPVNQTARP HCCCCCCCCCCCCCC | 35.45 | 29967540 | |
425 (in isoform 5) | Ubiquitination | - | 35.45 | 21906983 | |
433 | Phosphorylation | VNQTARPKTKPESSK CCCCCCCCCCCCCCC | 64.72 | 32142685 | |
436 (in isoform 6) | Ubiquitination | - | 52.51 | 21906983 | |
439 | Phosphorylation | PKTKPESSKGCESAV CCCCCCCCCCHHHHH | 31.25 | 21964256 | |
441 | Phosphorylation | TKPESSKGCESAVDE CCCCCCCCHHHHHHH | 23.52 | 32142685 | |
446 | Phosphorylation | SKGCESAVDELKGIL CCCHHHHHHHHHHHH | 9.05 | 32142685 | |
450 | Ubiquitination | ESAVDELKGILGTLN HHHHHHHHHHHHHCC | 41.69 | 29967540 | |
455 | Phosphorylation | ELKGILGTLNKSTSS HHHHHHHHCCCCCCC | 24.58 | 23312004 | |
455 (in isoform 6) | Ubiquitination | - | 24.58 | 21906983 | |
458 | Ubiquitination | GILGTLNKSTSSRSL HHHHHCCCCCCCCCH | 59.22 | 27667366 | |
459 | Phosphorylation | ILGTLNKSTSSRSLK HHHHCCCCCCCCCHH | 32.23 | 28857561 | |
460 | Phosphorylation | LGTLNKSTSSRSLKS HHHCCCCCCCCCHHH | 32.12 | 23312004 | |
461 | Phosphorylation | GTLNKSTSSRSLKSL HHCCCCCCCCCHHHC | 30.74 | 23312004 | |
462 | Phosphorylation | TLNKSTSSRSLKSLD HCCCCCCCCCHHHCC | 26.44 | 23312004 | |
464 | Phosphorylation | NKSTSSRSLKSLDPE CCCCCCCCHHHCCCC | 41.94 | 26657352 | |
464 (in isoform 5) | Ubiquitination | - | 41.94 | 21906983 | |
466 | Ubiquitination | STSSRSLKSLDPENS CCCCCCHHHCCCCCC | 50.66 | 21906983 | |
466 (in isoform 1) | Ubiquitination | - | 50.66 | 21906983 | |
466 (in isoform 3) | Ubiquitination | - | 50.66 | 21906983 | |
466 (in isoform 4) | Ubiquitination | - | 50.66 | 21906983 | |
467 | Phosphorylation | TSSRSLKSLDPENSE CCCCCHHHCCCCCCH | 43.21 | 29255136 | |
473 | Phosphorylation | KSLDPENSETELERI HHCCCCCCHHHHHHH | 44.21 | 25159151 | |
475 | Phosphorylation | LDPENSETELERILR CCCCCCHHHHHHHHH | 45.77 | 30206219 | |
485 | Ubiquitination | ERILRRRKVTAEADS HHHHHHCCCCCCCCC | 41.97 | 21906983 | |
485 (in isoform 1) | Ubiquitination | - | 41.97 | 21906983 | |
485 (in isoform 3) | Ubiquitination | - | 41.97 | 21906983 | |
485 (in isoform 4) | Ubiquitination | - | 41.97 | 21906983 | |
487 | Phosphorylation | ILRRRKVTAEADSSS HHHHCCCCCCCCCCC | 23.09 | 27273156 | |
492 | Phosphorylation | KVTAEADSSSPTGIL CCCCCCCCCCCCEEE | 39.50 | 30266825 | |
493 | Phosphorylation | VTAEADSSSPTGILA CCCCCCCCCCCEEEE | 40.67 | 30266825 | |
493 (in isoform 3) | Phosphorylation | - | 40.67 | 21406692 | |
494 | Phosphorylation | TAEADSSSPTGILAT CCCCCCCCCCEEEEE | 30.36 | 19664994 | |
494 (in isoform 6) | Ubiquitination | - | 30.36 | 21906983 | |
496 | Phosphorylation | EADSSSPTGILATSE CCCCCCCCEEEEECC | 38.51 | 30266825 | |
501 | Phosphorylation | SPTGILATSESKSMP CCCEEEEECCCCCCC | 29.58 | 30175587 | |
502 | Phosphorylation | PTGILATSESKSMPV CCEEEEECCCCCCCC | 33.98 | 23403867 | |
504 | Phosphorylation | GILATSESKSMPVLG EEEEECCCCCCCCEE | 29.78 | 23403867 | |
506 | Phosphorylation | LATSESKSMPVLGSV EEECCCCCCCCEECH | 37.28 | 29255136 | |
506 (in isoform 3) | Phosphorylation | - | 37.28 | 21406692 | |
512 | Phosphorylation | KSMPVLGSVSSVTKT CCCCCEECHHHHHHH | 18.05 | 23927012 | |
514 | Phosphorylation | MPVLGSVSSVTKTAL CCCEECHHHHHHHHH | 22.31 | 25159151 | |
515 | Phosphorylation | PVLGSVSSVTKTALN CCEECHHHHHHHHHC | 31.48 | 23927012 | |
517 | Phosphorylation | LGSVSSVTKTALNKK EECHHHHHHHHHCCC | 25.32 | 23927012 | |
519 | Phosphorylation | SVSSVTKTALNKKTL CHHHHHHHHHCCCCC | 27.32 | 22210691 | |
524 | Ubiquitination | TKTALNKKTLEAEFN HHHHHCCCCCEECCC | 58.21 | 21906983 | |
524 (in isoform 1) | Ubiquitination | - | 58.21 | 21906983 | |
524 (in isoform 3) | Ubiquitination | - | 58.21 | 21906983 | |
524 (in isoform 4) | Ubiquitination | - | 58.21 | 21906983 | |
525 | Phosphorylation | KTALNKKTLEAEFNS HHHHCCCCCEECCCC | 31.29 | 21815630 | |
532 | Phosphorylation | TLEAEFNSPSPPTPE CCEECCCCCCCCCCC | 31.88 | 25159151 | |
534 | Phosphorylation | EAEFNSPSPPTPEPG EECCCCCCCCCCCCC | 43.25 | 30278072 | |
537 | Phosphorylation | FNSPSPPTPEPGEGP CCCCCCCCCCCCCCC | 43.60 | 28355574 | |
556 | Phosphorylation | GCTSSKVTFQPPSSI CCCCCCEEECCCCCC | 21.93 | 23312004 | |
556 (in isoform 5) | Ubiquitination | - | 21.93 | 21906983 | |
561 | Phosphorylation | KVTFQPPSSIGCRKK CEEECCCCCCCCCHH | 41.07 | 25159151 | |
562 | Phosphorylation | VTFQPPSSIGCRKKY EEECCCCCCCCCHHC | 28.86 | 25159151 | |
586 | Phosphorylation | VVVLDPVSTHEPQTK EEEECCCCCCCCCCH | 29.45 | 28348404 | |
586 (in isoform 6) | Ubiquitination | - | 29.45 | 21906983 | |
587 | Phosphorylation | VVLDPVSTHEPQTKD EEECCCCCCCCCCHH | 30.41 | 28348404 | |
599 | Acetylation | TKDQVAEKDPTQHKE CHHHHCCCCCCCCCC | 60.31 | 26051181 | |
616 | Ubiquitination | GEIQPENKEDSIENV CCCCCCCHHHHHHHH | 62.33 | 2190698 | |
616 (in isoform 1) | Ubiquitination | - | 62.33 | 21906983 | |
619 | Phosphorylation | QPENKEDSIENVRET CCCCHHHHHHHHHHH | 32.66 | 25159151 | |
626 | Phosphorylation | SIENVRETDSSNC-- HHHHHHHHCCCCC-- | 30.53 | 29449344 | |
628 | Phosphorylation | ENVRETDSSNC---- HHHHHHCCCCC---- | 30.76 | 25627689 | |
629 | Phosphorylation | NVRETDSSNC----- HHHHHCCCCC----- | 45.05 | 25627689 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
101 | S | Phosphorylation | Kinase | PAK1 | Q13153 | Uniprot |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SHOT1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
UBXN1_HUMAN | UBXN1 | physical | 22939629 | |
UNK_HUMAN | UNK | physical | 22939629 | |
CAP1_HUMAN | CAP1 | physical | 22863883 | |
FAS_HUMAN | FASN | physical | 22863883 | |
ENPL_HUMAN | HSP90B1 | physical | 22863883 | |
KCD12_HUMAN | KCTD12 | physical | 22863883 | |
TPM4_HUMAN | TPM4 | physical | 22863883 | |
SHOT1_HUMAN | KIAA1598 | physical | 25416956 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-506, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-494 AND THR-496, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-494; SER-506; SER-515;SER-532 AND THR-537, AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-537, AND MASSSPECTROMETRY. |